ATW SPAC Management’s Envoy Medical COCH Stock Holding History

ATW SPAC Management’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100,000	Closed	-$1M	–	206
2023 Q1	$1M	Sell	100,000 -74,514	-43%	-$747K	0.33%	68
2022 Q4	$1.75M	Hold	174,514	–	–	0.41%	77
2022 Q3	$1.71M	Buy	174,514 +100,000	+134%	+$982K	0.27%	111
2022 Q2	$730K	Hold	74,514	–	–	0.1%	149
2022 Q1	$728	Hold	74,514	–	–	0.1%	150
2021 Q4	$726K	Hold	74,514	–	–	0.11%	145
2021 Q3	$724K	Hold	74,514	–	–	0.14%	112
2021 Q2	$725K	Buy	+74,514	New	+$724K	0.19%	96

Other funds holding COCH

AMC

Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

LIM

Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ATW SPAC Management's COCH Position: Q2 2023 in Review

ATW SPAC Management sold out of Envoy Medical (COCH) in Q2 2023, closing a stake of 100,000 shares — an estimated $1M sold.

ATW SPAC Management first reported a position in COCH in Q2 2021 and held it in 8 quarters. The position peaked at $1.75M in Q4 2022. 21 funds tracked by Wall St. Rank hold COCH as of Q2 2023.

ATW SPAC Management reported no remaining Envoy Medical position as of Q2 2023 after selling out during the quarter.
ATW SPAC Management sold 100,000 Envoy Medical shares in Q2 2023, an estimated $1M.
ATW SPAC Management first reported a position in Envoy Medical in Q2 2021 and held it in 8 quarters.
ATW SPAC Management's Envoy Medical position peaked at $1.75M in Q4 2022.
21 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2023.

Based on ATW SPAC Management's 13F filing for Q2 2023, filed 11 Aug 2023.